Painless cancer detection could become routine thanks to ‘liquid biopsies’

Health officials looking into link between Hepatitis C and opioids, encourage testing
June 24, 2017
How to Manage Multiple Sclerosis Relapses
June 26, 2017
Show all

Painless cancer detection could become routine thanks to ‘liquid biopsies’

‘Liquid biopsies’ could be used in the future to detect cancer.

Researchers are developing tests that could make cancer detection so painless that it becomes part of routine check-ups, experts said, as new developments in such “liquid biopsy” technology were presented at the world’s largest cancer conference in Chicago this weekend.

Collecting tumor tissue through biopsies is considered the gold standard for diagnosing and treating cancer. However, necessary surgery is often invasive and sometimes unsuccessful.

That has fueled interest in technology that uses blood samples to examine bits of DNA shed into the bloodstream by tumors. The hope, researchers say, is to save patients the pain of surgery, monitor tumor growth to tailor treatment and, ultimately, save lives.

“It’s fair to say that if you could detect all cancers while they are still localized, you could diminish cancer deaths by 90%,” said Dr Bert Vogelstein, a professor of oncology at Johns Hopkins School of Medicine who co-authored a study presented at the American Society of Clinical Oncology (ASCO) in Chicago.

“But that’s a theoretical figure. The available data suggests that it’s going to take quite a while, and there are a lot of obstacles to overcome.”

Read full article: Painless cancer detection could become routine thanks to ‘liquid biopsies’ | Science | The Guardian

Read Full Article: Painless cancer detection could become routine thanks to ‘liquid biopsies’ | Science | The Guardian

The health and medical information on our website is not intended to take the place of advice or treatment from health care professionals. It is also not intended to substitute for the users’ relationships with their own health care/pharmaceutical providers.

Comments are closed.